SWM
ABBV icon

SHP Wealth Management’s AbbVie ABBV Stock Holding History

SHP Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Buy
9,666
+11
+0.1% +$2.44K 0.16% 44
2025
Q4 		$2.21M Buy
+9,655
New +$2.2M 0.17% 44

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SHP Wealth Management's ABBV Position: Q1 2026 in Review

SHP Wealth Management increased its AbbVie (ABBV) stake by 0.11% in Q1 2026, buying an estimated $2.44K and bringing the position to 9,666 shares worth $2.1M. The position accounts for 0.16% of the portfolio, ranked #44.

SHP Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.21M in Q4 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • SHP Wealth Management held 9,666 shares of AbbVie worth $2.1M as of Q1 2026.
  • SHP Wealth Management bought 11 AbbVie shares in Q1 2026, an estimated $2.44K.
  • AbbVie made up 0.16% of SHP Wealth Management's portfolio in Q1 2026, its #44 holding.
  • SHP Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's AbbVie position peaked at $2.21M in Q4 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.